Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

24 Jul 2014 07:00

RNS Number : 1641N
Halma PLC
24 July 2014
 



Halma plc

 

AGM/Interim Management Statement

 

24 July 2014

 

 

Halma, the leading safety, health and environmental technology group is holding its 120th AGM later today and makes the following Interim Management Statement relating to the period 30 March 2014 to date, with comments on trading relating to the first quarter ended 28 June 2014.

 

Market conditions have remained varied within our four sectors and the major geographic regions, while the increasing strength of sterling continues to provide a translation headwind. However, Halma has continued to achieve organic revenue growth at constant currency with order intake at 103% of revenue. This, together with the acquisitions completed in the first quarter, has positioned Halma to make further progress in the year ahead in line with the Board's expectations.

 

Process Safety performed well with growth from the USA, Mainland Europe, Middle East and South America offsetting lower revenue from Asia Pacific. The integration of RCS, the pipeline corrosion monitoring business acquired in May 2014, has started well and collaboration with Halma's other Process Safety companies is already underway.

 

The Infrastructure Safety sector made solid progress with encouraging growth in the UK and Mainland Europe. The integration into Halma of Advanced Electronics, the fire safety company acquired in May 2014, is also proceeding well.

 

Our Medical sector had a slow start to the year but is gaining momentum with good underlying growth in the USA and South America. Plasticspritzerei, acquired in May 2014, has been fully integrated into Medicel, the Halma company which manufactures devices for cataract surgery procedures.

 

The Environmental & Analysis sector delivered a mixed performance. Revenue growth in Mainland Europe and Asia Pacific has been encouraging although trading in the USA and UK has been more challenging. UK revenue has been affected by lower spending by water utilities which are now in the final year of their 5-year investment cycle.

 

As reported previously, since the start of the period we have completed three acquisitions and one disposal with a net cash cost of £78m. There have been no other material events or transactions during the period impacting upon the Group's financial position, which remains strong. We continue to identify potential acquisition opportunities which meet our strategic and financial criteria.

 

The half yearly results for the period ending 27 September 2014 are expected to be released on 18 November 2014.

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

 

 

NOTE TO EDITORS

 

1.

Halma develops and markets products used worldwide to protect life and improve the quality of life. The Group comprises four business sectors:

 

● Process Safety

Products which protect assets and people at work.

 

● Infrastructure Safety

Products which detect hazards to protect assets and people in public spaces and commercial buildings.

 

● Medical

Products used to improve personal and public health.

 

● Environmental & Analysis

Products and technologies for analysis in safety, life sciences and environmental markets.

 

The key characteristics of Halma's businesses are that they are based on specialist technology and application knowledge, offering strong growth potential. Many Group businesses are market leaders in their specialist field.

 

2.

High resolution photos of Halma senior management, including Chief Executive Andrew Williams, and images illustrating Halma business activities can be downloaded from its website: www.halma.com. Click on the 'News & Media' link, then 'Image Library'. Photo queries: David Waller +44 (0)1494 721111, e-mail: dwaller@halmapr.com.

 

3.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma plc, in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

4.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMGZNVFMGDZM
Date   Source Headline
21st Nov 20177:00 amRNSHalf-year Report
1st Nov 20177:00 amRNSAcquisition
4th Oct 20175:54 pmRNSDirector/PDMR Shareholding
28th Sep 20179:57 amRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSTrading Statement
11th Sep 201712:19 pmRNSDirector Declaration
7th Sep 20179:27 amRNSDirector Declaration
1st Sep 20175:08 pmRNSTotal Voting Rights
16th Aug 20174:02 pmRNSDirector/PDMR Shareholding
7th Aug 20177:00 amRNSAcquisition
1st Aug 201710:39 amRNSTotal Voting Rights
31st Jul 201712:00 pmRNSNotice of Board Change
20th Jul 20173:57 pmRNSResult of AGM
19th Jul 20172:21 pmRNSDirector Declaration
4th Jul 20173:39 pmRNSDirector/PDMR Shareholding
3rd Jul 201711:29 amRNSTotal Voting Rights
21st Jun 20175:22 pmRNSAnnual Financial Report
13th Jun 20177:00 amRNSFinal Results
1st Jun 20173:02 pmRNSTotal Voting Rights
30th May 201711:00 amRNSNotice of Results
2nd May 20173:39 pmRNSTotal Voting Rights
6th Apr 20179:00 amRNSNotice of Board change
3rd Apr 201711:12 amRNSTotal Voting Rights
23rd Mar 20177:00 amRNSTrading Update and Audit Tender
1st Mar 201712:41 pmRNSTotal Voting Rights
13th Feb 20174:06 pmRNSHolding(s) in Company
1st Feb 201712:07 pmRNSTotal Voting Rights
9th Jan 20179:00 amRNSAcquisition of FluxData
3rd Jan 20174:02 pmRNSTotal Voting Rights
1st Dec 201611:37 amRNSTotal Voting Rights
28th Nov 20163:05 pmRNSDirector/PDMR Shareholding
24th Nov 20164:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:35 pmRNSDoc re. Half Yearly Report
22nd Nov 20167:00 amRNSHalf-year Report
1st Nov 20164:43 pmRNSTotal Voting Rights
5th Oct 20165:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20164:31 pmRNSTotal Voting Rights
29th Sep 201610:00 amRNSInvestor Event
27th Sep 20169:37 amRNSDirectorate Change
23rd Sep 20164:27 pmRNSDirectorate Change
1st Sep 20165:25 pmRNSTotal Voting Rights
22nd Aug 20163:54 pmRNSDirector/PDMR Shareholding
10th Aug 20163:26 pmRNSDirector/PDMR Shareholding
1st Aug 20169:00 amRNSTotal Voting Rights
28th Jul 20163:06 pmRNSDirector/PDMR Shareholding
21st Jul 20166:01 pmRNSResult of AGM
21st Jul 20167:00 amRNSAGM Trading Update
1st Jul 201612:58 pmRNSTotal Voting Rights
21st Jun 20162:38 pmRNSAnnual Financial Report
14th Jun 20167:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.